op 2507 has been researched along with Disease Models, Animal in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Iida, T; Kawarada, Y; Yokoi, H | 1 |
| Chen, HM; Chen, MF; Shyr, MH | 1 |
| Chen, HM; Chen, JC; Chen, MF; Chiu, DF; Ng, CJ; Shyr, MH | 1 |
3 other study(ies) available for op 2507 and Disease Models, Animal
| Article | Year |
|---|---|
The effects of a thromboxane A2 synthesis inhibitor and a prostaglandin I2 analogue on experimental acute necrotizing pancreatitis in rats.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Disease Models, Animal; Epoprostenol; Injections, Subcutaneous; Kidney; Lung; Male; Methacrylates; Pancreas; Pancreatitis, Acute Necrotizing; Phospholipases A; Phospholipases A2; Rats; Rats, Wistar; Survival Rate; Taurocholic Acid; Thromboxane A2; Thromboxane B2; Thromboxane-A Synthase; Time Factors | 1998 |
Prostacyclin analogue (OP-2507) attenuates hepatic microcirculatory derangement, energy depletion, and lipid peroxidation in a rat model of reperfusion injury.
Topics: Adenosine Triphosphate; Animals; Blood Flow Velocity; Blood Pressure; Disease Models, Animal; Energy Metabolism; Epoprostenol; Infusions, Intravenous; Leukocytes; Lipid Peroxidation; Liver; Liver Circulation; Male; Malondialdehyde; Microcirculation; Rats; Rats, Sprague-Dawley; Reperfusion Injury; Time Factors | 1998 |
Prostacyclin analogue (OP-2507) induces delayed ex vivo neutrophil apoptosis and attenuates reperfusion-induced hepatic microcirculatory derangement in rats.
Topics: Animals; Apoptosis; CD18 Antigens; Disease Models, Animal; Dose-Response Relationship, Drug; Epoprostenol; In Vitro Techniques; Liver; Liver Circulation; Male; Neutrophils; Rats; Rats, Sprague-Dawley; Reperfusion Injury | 2001 |